Next Article in Journal
Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis
Next Article in Special Issue
A Review of Topical Phage Therapy for Chronically Infected Wounds and Preparations for a Randomized Adaptive Clinical Trial Evaluating Topical Phage Therapy in Chronically Infected Diabetic Foot Ulcers
Previous Article in Journal
Impact of a Diagnosis-Centered Antibiotic Stewardship on Incident Clostridioides difficile Infections in Older Inpatients: An Observational Study
Previous Article in Special Issue
Adapting a Phage to Combat Phage Resistance
Review

Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli

Department of Molecular Biotechnology and Microbiology, Chemical Faculty, Gdańsk University of Technology, Narutowicza 11/12, 80-233 Gdańsk, Poland
*
Author to whom correspondence should be addressed.
Received: 4 May 2020 / Revised: 2 June 2020 / Accepted: 3 June 2020 / Published: 5 June 2020
Urinary tract infections (UTIs) are regarded as one of the most common bacterial infections affecting millions of people, in all age groups, annually in the world. The major causative agent of complicated and uncomplicated UTIs are uropathogenic E. coli strains (UPECs). Huge problems with infections of this type are their chronicity and periodic recurrences. Other disadvantages that are associated with UTIs are accompanying complications and high costs of health care, systematically increasing resistance of uropathogens to routinely used antibiotics, as well as biofilm formation by them. This creates the need to develop new approaches for the prevention and treatment of UTIs, among which phage therapy has a dominant potential to eliminate uropathogens within urinary tract. Due to the growing interest in such therapy in the last decade, the bacteriophages (natural, genetically modified, engineered, or combined with antibiotics or disinfectants) represent an innovative antimicrobial alternative and a strategy for managing the resistance of uropathogenic microorganisms and controlling UTIs. View Full-Text
Keywords: urinary tract infections; uropathogenic E. coli; antibiotics; alternative treatment; bacteriophages; phage therapy urinary tract infections; uropathogenic E. coli; antibiotics; alternative treatment; bacteriophages; phage therapy
MDPI and ACS Style

Zalewska-Piątek, B.; Piątek, R. Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli. Antibiotics 2020, 9, 304. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9060304

AMA Style

Zalewska-Piątek B, Piątek R. Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli. Antibiotics. 2020; 9(6):304. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9060304

Chicago/Turabian Style

Zalewska-Piątek, Beata, and Rafał Piątek. 2020. "Phage Therapy as a Novel Strategy in the Treatment of Urinary Tract Infections Caused by E. Coli" Antibiotics 9, no. 6: 304. https://0-doi-org.brum.beds.ac.uk/10.3390/antibiotics9060304

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop